These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
936 related articles for article (PubMed ID: 27599332)
1. Primary Care Screening and Treatment for Latent Tuberculosis Infection in Adults: Evidence Report and Systematic Review for the US Preventive Services Task Force. Kahwati LC; Feltner C; Halpern M; Woodell CL; Boland E; Amick HR; Weber RP; Jonas DE JAMA; 2016 Sep; 316(9):970-83. PubMed ID: 27599332 [TBL] [Abstract][Full Text] [Related]
2. Screening for Latent Tuberculosis Infection in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. Jonas DE; Riley SR; Lee LC; Coffey CP; Wang SH; Asher GN; Berry AM; Williams N; Balio C; Voisin CE; Kahwati LC JAMA; 2023 May; 329(17):1495-1509. PubMed ID: 37129650 [TBL] [Abstract][Full Text] [Related]
3. Interferon-γ release assays or tuberculin skin test for detection and management of latent tuberculosis infection: a systematic review and meta-analysis. Zhou G; Luo Q; Luo S; Teng Z; Ji Z; Yang J; Wang F; Wen S; Ding Z; Li L; Chen T; Abi ME; Jian M; Luo L; Liu A; Bao F Lancet Infect Dis; 2020 Dec; 20(12):1457-1469. PubMed ID: 32673595 [TBL] [Abstract][Full Text] [Related]
4. Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB. Sharma SK; Sharma A; Kadhiravan T; Tharyan P Evid Based Child Health; 2014 Mar; 9(1):169-294. PubMed ID: 25404581 [TBL] [Abstract][Full Text] [Related]
5. Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries. Getahun H; Matteelli A; Abubakar I; Aziz MA; Baddeley A; Barreira D; Den Boon S; Borroto Gutierrez SM; Bruchfeld J; Burhan E; Cavalcante S; Cedillos R; Chaisson R; Chee CB; Chesire L; Corbett E; Dara M; Denholm J; de Vries G; Falzon D; Ford N; Gale-Rowe M; Gilpin C; Girardi E; Go UY; Govindasamy D; D Grant A; Grzemska M; Harris R; Horsburgh CR; Ismayilov A; Jaramillo E; Kik S; Kranzer K; Lienhardt C; LoBue P; Lönnroth K; Marks G; Menzies D; Migliori GB; Mosca D; Mukadi YD; Mwinga A; Nelson L; Nishikiori N; Oordt-Speets A; Rangaka MX; Reis A; Rotz L; Sandgren A; Sañé Schepisi M; Schünemann HJ; Sharma SK; Sotgiu G; Stagg HR; Sterling TR; Tayeb T; Uplekar M; van der Werf MJ; Vandevelde W; van Kessel F; van't Hoog A; Varma JK; Vezhnina N; Voniatis C; Vonk Noordegraaf-Schouten M; Weil D; Weyer K; Wilkinson RJ; Yoshiyama T; Zellweger JP; Raviglione M Eur Respir J; 2015 Dec; 46(6):1563-76. PubMed ID: 26405286 [TBL] [Abstract][Full Text] [Related]
6. Interferon-gamma release assay for the diagnosis of latent tuberculosis infection: A latent-class analysis. Doan TN; Eisen DP; Rose MT; Slack A; Stearnes G; McBryde ES PLoS One; 2017; 12(11):e0188631. PubMed ID: 29182688 [TBL] [Abstract][Full Text] [Related]
7. Predictive value of interferon-γ release assays and tuberculin skin testing for progression from latent TB infection to disease state: a meta-analysis. Diel R; Loddenkemper R; Nienhaus A Chest; 2012 Jul; 142(1):63-75. PubMed ID: 22490872 [TBL] [Abstract][Full Text] [Related]
8. Management of latent tuberculosis infection in China: Exploring solutions suitable for high-burden countries. Cui X; Gao L; Cao B Int J Infect Dis; 2020 Mar; 92S():S37-S40. PubMed ID: 32114201 [TBL] [Abstract][Full Text] [Related]
9. A prospective cohort study of latent tuberculosis in adult close contacts of active pulmonary tuberculosis patients in Korea. Park SH; Lee SJ; Cho YJ; Jeong YY; Kim HC; Lee JD; Kim HJ; Menzies D Korean J Intern Med; 2016 May; 31(3):517-24. PubMed ID: 27052266 [TBL] [Abstract][Full Text] [Related]
10. Latent Tuberculosis in Pregnancy: A Systematic Review. Malhamé I; Cormier M; Sugarman J; Schwartzman K PLoS One; 2016; 11(5):e0154825. PubMed ID: 27149116 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of the usefulness of interferon-gamma release assays and the tuberculin skin test for the detection of latent Mycobacterium tuberculosis infections in Korean rheumatic patients who are candidates for biologic agents. Kim JH; Won S; Choi CB; Sung YK; Song GG; Bae SC Int J Rheum Dis; 2015 Mar; 18(3):315-22. PubMed ID: 25351815 [TBL] [Abstract][Full Text] [Related]
12. A systematic review on TST and IGRA tests used for diagnosis of LTBI in immigrants. Campbell JR; Krot J; Elwood K; Cook V; Marra F Mol Diagn Ther; 2015 Feb; 19(1):9-24. PubMed ID: 25579159 [TBL] [Abstract][Full Text] [Related]
13. Interferon gamma release assay tests are associated with persistence and completion of latent tuberculosis infection treatment in the United States: Evidence from commercial insurance data. Stockbridge EL; Loethen AD; Annan E; Miller TL PLoS One; 2020; 15(12):e0243102. PubMed ID: 33270737 [TBL] [Abstract][Full Text] [Related]
15. A Step toward Tuberculosis Elimination in a Low-Incidence Country: Successful Diagnosis and Treatment of Latent Tuberculosis Infection in a Refugee Clinic. Rennert-May E; Hansen E; Zadeh T; Krinke V; Houston S; Cooper R Can Respir J; 2016; 2016():7980869. PubMed ID: 27445565 [TBL] [Abstract][Full Text] [Related]
16. The utility of an interferon gamma release assay for diagnosis of latent tuberculosis infection and disease in children: a systematic review and meta-analysis. Machingaidze S; Wiysonge CS; Gonzalez-Angulo Y; Hatherill M; Moyo S; Hanekom W; Mahomed H Pediatr Infect Dis J; 2011 Aug; 30(8):694-700. PubMed ID: 21427627 [TBL] [Abstract][Full Text] [Related]
17. Contribution of interferon-γ release assays (IGRAs) to the diagnosis of latent tuberculosis infection after renal transplantation. Hadaya K; Bridevaux PO; Roux-Lombard P; Delort A; Saudan P; Martin PY; Janssens JP Transplantation; 2013 Jun; 95(12):1485-90. PubMed ID: 23694948 [TBL] [Abstract][Full Text] [Related]